Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hermens

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
The American Journal of Cardiology|January 1, 1988
Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatmentA van der Laarse, P L Kerkhof, F Vermeer, et al.
Human Gene Therapy|September 9, 2004
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutationColin J D Ross, Jaap Twisk, Janneke M Meulenberg, et al.
Circulation|November 15, 1995
Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding proteinF A Van Nieuwenhoven, A H Kleine, W H Wodzig, et al.
American Heart Journal|April 1, 1988
Rapid enzyme release from acutely infarcted myocardium after early thrombolytic therapy: washout or reperfusion damage?A van der Laarse, E E van der Wall, R C van den Pol, et al.
European Heart Journal|October 26, 2002
Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarctionC de Zwaan, A H Kleine, J H C Diris, et al.
Experimental and Molecular Pathology|August 30, 2008
Release kinetics of intact and degraded troponin I and T after irreversible cell damageM H M Hessel, E C H J Michielsen, D E Atsma, et al.
Clinical Chemistry|June 26, 2004
Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utilityMaurice M A L Pelsers, Thorsten Hanhoff, Daniëlle Van der Voort, et al.
Human Gene Therapy|November 2, 2005
Gene therapy for lipoprotein lipase deficiency: working toward clinical applicationJaap Rip, Melchior C Nierman, Jeroen A Sierts, et al.
Molecular Cancer Therapeutics|April 12, 2023
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody-Drug ConjugatePatrick G Groothuis, Daniëlle C H Jacobs, Inge A T Hermens, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
The American Journal of Cardiology|January 1, 1988
Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatmentA van der Laarse, P L Kerkhof, F Vermeer, et al.
Human Gene Therapy|September 9, 2004
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutationColin J D Ross, Jaap Twisk, Janneke M Meulenberg, et al.
Circulation|November 15, 1995
Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding proteinF A Van Nieuwenhoven, A H Kleine, W H Wodzig, et al.
American Heart Journal|April 1, 1988
Rapid enzyme release from acutely infarcted myocardium after early thrombolytic therapy: washout or reperfusion damage?A van der Laarse, E E van der Wall, R C van den Pol, et al.
European Heart Journal|October 26, 2002
Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarctionC de Zwaan, A H Kleine, J H C Diris, et al.
Experimental and Molecular Pathology|August 30, 2008
Release kinetics of intact and degraded troponin I and T after irreversible cell damageM H M Hessel, E C H J Michielsen, D E Atsma, et al.
Clinical Chemistry|June 26, 2004
Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utilityMaurice M A L Pelsers, Thorsten Hanhoff, Daniëlle Van der Voort, et al.
Human Gene Therapy|November 2, 2005
Gene therapy for lipoprotein lipase deficiency: working toward clinical applicationJaap Rip, Melchior C Nierman, Jeroen A Sierts, et al.
Molecular Cancer Therapeutics|April 12, 2023
Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody-Drug ConjugatePatrick G Groothuis, Daniëlle C H Jacobs, Inge A T Hermens, et al.
Pageof 13